The relentless pursuit of new and effective pharmaceuticals hinges on the availability of precise and reliable chemical intermediates. 4-Bromo-2-fluorophenylacetic acid, identified by its CAS number 114897-92-6, stands as a testament to this, serving as a cornerstone for numerous drug discovery and development programs.

This compound’s significance in the pharmaceutical industry is rooted in its structure as a halogenated phenylacetic acid derivative. The strategic placement of bromine and fluorine atoms on the aromatic ring, alongside the reactive carboxylic acid group, makes it an exceptionally versatile building block for medicinal chemists. It allows for a wide array of synthetic transformations, enabling the creation of complex molecular scaffolds that are often the basis of new therapeutic agents.


In the intricate process of drug discovery, intermediates like 4-Bromo-2-fluorophenylacetic acid are indispensable. They provide the necessary chemical handles for coupling reactions, cyclizations, and other sophisticated synthetic steps required to build drug candidates. The high purity typically offered by manufacturers, such as NINGBO INNO PHARMCHEM CO.,LTD., ensures that these critical synthesis steps proceed smoothly, yielding desired products with high efficiency and minimal byproducts.


When companies decide to buy 4-Bromo-2-fluorophenylacetic acid, they are investing in a compound that can accelerate their research and development timelines. Access to a dependable supplier network, particularly from established chemical manufacturing hubs like China, is crucial. NINGBO INNO PHARMCHEM CO.,LTD. is recognized for its commitment to quality and its role in supplying essential intermediates that power the pharmaceutical sector.


The successful development of new drugs often relies on the quality and availability of foundational chemical components. 4-Bromo-2-fluorophenylacetic acid is a prime example of such a component, facilitating innovation in medicinal chemistry. By partnering with reliable suppliers, the pharmaceutical industry can continue to bring life-changing treatments to patients worldwide.